Clinical applications of FDG-PET in oncology

被引：28

作者：

Czernin, J ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Clin, Los Angeles, CA 90024 USA

来源：

ACTA MEDICA AUSTRIACA | 2002年 / 29卷 / 05期

关键词：

positron emission tomography; oncology; FDG;

D O I：

10.1046/j.1563-2571.2002.02042.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Positron emission tomography together with F-18-deoxyglucose (FDG) has emerged as a valuable clinical tool in the field of oncology. FDG-PET diagnoses, stages and restages most cancers with a high diagnostic accuracy. The effects of chemotherapy on tumour metabolism can be monitored with this whole-body technique. Recent studies have established a high prognostic accuracy of PET for predicting the clinical outcome of cancer patients. The current review addresses the role of FDG-PET for diagnosing, staging and restaging of lung cancer, colorectal cancer, lymphoma, melanoma and breast cancer staging and provides a brief outlook for future applications of clinical PET imaging.

引用

收藏

页码：162 / 170

页数：9

相关论文

共 94 条

[21] DIAGNOSTIC EFFICACY OF PET-FDG IMAGING IN SOLITARY PULMONARY NODULES - POTENTIAL ROLE IN EVALUATION AND MANAGEMENT [J].

DEWAN, NA ;

GUPTA, NC ;

REDEPENNING, LS ;

PHALEN, JJ ;

FRICK, MP .

CHEST, 1993, 104 (04) :997-1002

[22] Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma [J].

deWit, M ;

Bumann, D ;

Beyer, W ;

Herbst, K ;

Clausen, M ;

Hossfeld, DK .

ANNALS OF ONCOLOGY, 1997, 8 :57-60

[23] DETECTION OF PRIMARY AND RECURRENT LUNG-CANCER BY MEANS OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG PET) [J].

DUHAYLONGSOD, FG ;

LOWE, VJ ;

PATZ, EF ;

VAUGHN, AL ;

COLEMAN, RE ;

WOLFE, WG .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :130-140

[24] Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].

Dwamena, BA ;

Sonnad, SS ;

Angobaldo, JO ;

Wahl, RL .

RADIOLOGY, 1999, 213 (02) :530-536

[25] Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma [J].

Eigtved, A ;

Andersson, AP ;

Dahlstrom, K ;

Rabol, A ;

Jensen, M ;

Holm, S ;

Sorensen, SS ;

Drzewiecki, KT ;

Hojgaard, L ;

Friberg, L .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (01) :70-75

[26]

Filmont J, 2001, J NUCL MED, V42, p124P

[27]

Filmont JE, 2001, J NUCL MED, V42, p269P

[28] ELEVATED LEVELS OF GLUCOSE-TRANSPORT AND TRANSPORTER MESSENGER-RNA ARE INDUCED BY RAS OR SRC ONCOGENES [J].

FLIER, JS ;

MUECKLER, MM ;

USHER, P ;

LODISH, HF .

SCIENCE, 1987, 235 (4795) :1492-1495

[29] Breast cancers invisible on mammography [J].

Foxcroft, LM ;

Evans, EB ;

Joshua, HK ;

Hirst, C .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 2000, 70 (03) :162-167

[30] Analytical decision model for the cost-effective management of solitary pulmonary nodules [J].

Gambhir, SS ;

Shepherd, JE ;

Shah, BD ;

Hart, E ;

Hoh, CK ;

Valk, PE ;

Emi, T ;

Phelps, ME .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2113-2125

← 1 2 3 4 5 6 7 8 9 10 →